Health
Study characterizes cisplatin-induced hearing loss in pediatric cancer patients – News-Medical.Net
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases.
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases. Permanent hearing loss is a common side effect of this medication, but until now, studies have been too small and too varied to accurately characterize this risk.
Today in The Lancet Child & Adolescent Health, investigators at Children’s Hospital Los Angeles published results of the largest study of cisplatin-induced hearing loss to date. The study establishes the first benchmarks for the…
-
Noosa News22 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
General12 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
Noosa News11 hours agoFarmers call for policy reform across multiple sectors as productivity collapses
-
General15 hours agoCoalition to chart path forward as family feud cooled